Thrombate III Home
Thrombate III, Antithrombin III (Human), is indicated for the treatment of patients with
hereditary antithrombin (AT) deficiency in connection with surgical or obstetrical procedures or when they
suffer from thromboembolism. 1
Necessary: The Only FDA-Approved Treatment for Hereditary AT Deficiency
Efficacious. Thrombate III is a potent hemostatic agent that restores
the balance in hemostasis for patients with hereditary antithrombin deficiency in high-risk situations.
| |
• |
Thrombate III reduces the risk of thrombotic events without increasing the risk of bleeding |
Predictable. Thrombate III is highly purified antithrombin concentrate that gives physicians precise control over antithrombin levels.
| |
• |
Thrombate III is purified to remove other coagulation proteins |
Safe. Thrombate III has a well-established safety profile.
| |
• |
Thrombate III has more than 15 years of post-marketing experience |
| |
• |
More than 100 million IUs have been administered with no reported case of virus transmission |
| |
• |
Thrombate III is pasteurized to inactivate viruses and is purified to remove proinflammatory antibodies and cytokines |
| |
• |
Thrombate III has a low incidence of side effects.1
The most common include dizziness, chest tightness, nausea, and a foul taste in the mouth |
Reference:
| 1. |
|
Thrombate III [prescribing information]. Research Triangle Park, NC; Talecris Biotherapeutics, Inc.; 2006.
|
|